William H. R. Langridge

4.9k total citations
117 papers, 3.7k citations indexed

About

William H. R. Langridge is a scholar working on Molecular Biology, Biotechnology and Immunology. According to data from OpenAlex, William H. R. Langridge has authored 117 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 47 papers in Biotechnology and 27 papers in Immunology. Recurrent topics in William H. R. Langridge's work include Transgenic Plants and Applications (46 papers), Plant tissue culture and regeneration (22 papers) and CRISPR and Genetic Engineering (20 papers). William H. R. Langridge is often cited by papers focused on Transgenic Plants and Applications (46 papers), Plant tissue culture and regeneration (22 papers) and CRISPR and Genetic Engineering (20 papers). William H. R. Langridge collaborates with scholars based in United States, South Korea and Canada. William H. R. Langridge's co-authors include Daniel K.X. Chong, Takeshi Arakawa, Dequina Nicholas, Jie Yu, Aladar A. Szalay, Jacques Mbongue, Anthony Firek, Timothy Torrez, Nan-Sun Kim and Csaba Koncz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

William H. R. Langridge

116 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William H. R. Langridge United States 30 2.3k 1.6k 898 674 408 117 3.7k
Pieter Rottiers Belgium 25 1.4k 0.6× 318 0.2× 719 0.8× 247 0.4× 418 1.0× 46 3.0k
Hua Shen United States 39 1.9k 0.9× 217 0.1× 645 0.7× 96 0.1× 582 1.4× 96 3.5k
Gudula Schmidt Germany 38 2.5k 1.1× 132 0.1× 934 1.0× 151 0.2× 551 1.4× 95 4.4k
Anna Sokolovska United States 18 1.3k 0.6× 498 0.3× 1.2k 1.3× 75 0.1× 352 0.9× 24 2.8k
Joseph Barbieri United States 50 3.6k 1.6× 313 0.2× 1.9k 2.1× 180 0.3× 1.0k 2.5× 175 7.6k
G K McMaster Switzerland 16 1.8k 0.8× 87 0.1× 382 0.4× 418 0.6× 444 1.1× 19 3.2k
David G. Klapper United States 35 1.5k 0.7× 125 0.1× 600 0.7× 119 0.2× 260 0.6× 82 3.6k
Céline Deraison France 25 1.2k 0.5× 163 0.1× 338 0.4× 187 0.3× 124 0.3× 61 3.2k
Nafisa Ghori United States 19 1.2k 0.5× 110 0.1× 805 0.9× 149 0.2× 698 1.7× 20 3.1k
Yasuyuki Imai Japan 24 947 0.4× 97 0.1× 780 0.9× 138 0.2× 455 1.1× 99 2.6k

Countries citing papers authored by William H. R. Langridge

Since Specialization
Citations

This map shows the geographic impact of William H. R. Langridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. R. Langridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. R. Langridge more than expected).

Fields of papers citing papers by William H. R. Langridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. R. Langridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. R. Langridge. The network helps show where William H. R. Langridge may publish in the future.

Co-authorship network of co-authors of William H. R. Langridge

This figure shows the co-authorship network connecting the top 25 collaborators of William H. R. Langridge. A scholar is included among the top collaborators of William H. R. Langridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. R. Langridge. William H. R. Langridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kabagwira, Janviere, et al.. (2024). Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment. OncoTargets and Therapy. Volume 17. 63–78. 1 indexed citations
2.
Nicholas, Dequina, et al.. (2024). Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes. SHILAP Revista de lepidopterología. 4(1). 91–107. 8 indexed citations
3.
Mbongue, Jacques, et al.. (2023). Exploring the Potential of Plant-Based CTB-INS Oral Vaccines in Treating Type 1 Diabetes. SHILAP Revista de lepidopterología. 3(2). 217–227.
4.
Dénes, Béla, et al.. (2023). A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection. Vaccines. 11(12). 1865–1865. 4 indexed citations
5.
Mbongue, Jacques, et al.. (2022). Lipopolysaccharide-Induced Immunological Tolerance in Monocyte-Derived Dendritic Cells. SHILAP Revista de lepidopterología. 2(3). 482–500. 15 indexed citations
6.
Nicholas, Dequina, Lorena Salto, W. Lawrence Beeson, et al.. (2020). En Balance: The Contribution of Physical Activity to the Efficacy of Spanish Diabetes Education of Hispanic Americans with Type 2 Diabetes. Journal of Diabetes Research. 2020. 1–8. 1 indexed citations
7.
Nicholas, Dequina, Kangling Zhang, Christopher Hung, et al.. (2017). Palmitic acid is a toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1β. PLoS ONE. 12(5). e0176793–e0176793. 89 indexed citations
8.
Kim, Nan-Sun, Jacques Mbongue, Dequina Nicholas, et al.. (2016). Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway. PLoS ONE. 11(2). e0147509–e0147509. 14 indexed citations
9.
Estes, Mary K., et al.. (2006). Ricin Toxin B Subunit Enhancement of Rotavirus NSP4 Immunogenicity in Mice. Viral Immunology. 19(1). 54–63. 10 indexed citations
10.
Estes, Mary K., et al.. (2005). Synthesis and assembly of a cholera toxin B subunit-rotavirus VP7 fusion protein in transgenic potato. Molecular Biotechnology. 31(3). 193–202. 32 indexed citations
11.
Yu, Jie, et al.. (2005). Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis. Molecular Biotechnology. 32(1). 1–15. 20 indexed citations
12.
Dénes, Béla, Tatyana M. Timiryasova, David C. Henderson, et al.. (2005). Protection of NOD Mice From Type 1 Diabetes After Oral Inoculation with Vaccinia Viruses Expressing Adjuvanted Islet Autoantigens. Journal of Immunotherapy. 28(5). 438–448. 17 indexed citations
13.
Langridge, William H. R., et al.. (2003). Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato. Plant Cell Reports. 21(9). 884–890. 40 indexed citations
14.
Langridge, William H. R., et al.. (2001). Synthesis and assembly of cholera holotoxin in potato plants. 3(2). 167–174. 1 indexed citations
15.
Arakawa, T., et al.. (2001). Assembly of cholera toxin-antigen fusion proteins in transgenic potato. 3(2). 153–162. 4 indexed citations
16.
Arakawa, Takeshi, et al.. (1999). Suppression of autoimmune diabetes by a plant-delivered cholera toxin B subunit-human glutamate decarboxylase fusion protein. 3. 51–60. 18 indexed citations
17.
Timiryasova, Tatyana M., et al.. (1998). Vaccinia Virus Mediated in Vitro and ex Vivo Delivery of the P53 Gene into Glioma Cells for Therapy of Glial Tumors. Cancer Gene Therapy. 4(6). 1 indexed citations
18.
Langridge, William H. R., et al.. (1985). Electric field mediated stable transformation of carrot protoplasts with naked DNA. Plant Cell Reports. 4(6). 355–359. 42 indexed citations
19.
Wood, H. A., et al.. (1981). Increased virulence of Autographa californica nuclear polyhedrosis virus by mutagenesis. Journal of Invertebrate Pathology. 38(2). 236–241. 23 indexed citations
20.
Szalay, Aladar A., Catherine J. Mackey, & William H. R. Langridge. (1979). Restriction endonucleases and their applications. Enzyme and Microbial Technology. 1(3). 154–164. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter Rottiers Breakdown of academic impact, for papers by Hua Shen Breakdown of academic impact, for papers by Gudula Schmidt Breakdown of academic impact, for papers by Anna Sokolovska Breakdown of academic impact, for papers by Joseph Barbieri Breakdown of academic impact, for papers by G K McMaster Breakdown of academic impact, for papers by David G. Klapper Breakdown of academic impact, for papers by Céline Deraison Breakdown of academic impact, for papers by Nafisa Ghori Breakdown of academic impact, for papers by Yasuyuki Imai
Rankless by CCL
2026